KIORA PHARMACEUTICALS, INC. Equity Method Investment, Ownership Percentage
KIORA PHARMACEUTICALS, INC. (KPRX) had Equity Method Investment, Ownership Percentage of 50.01% as of 2014-12-31, per its 10-K filed 2016-03-30.
Discontinued › Notes
us-gaap:EquityMethodInvestmentOwnershipPercentage · last filed 2016-03-30
- 2014-12-31: Equity Method Investment, Ownership Percentage 50.01%.
| Period end | Equity Method Investment, Ownership Percentage |
|---|---|
| 2014-12-31 | 50.01% 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |